M. Kinoshita

发表

Treatment - therapeutic lifestyle modification.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

Other high-risk conditions.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

Cerebrovascular diseases.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Committee Report 3 Goals of Dyslipidemia Management

T. Funahashi, K. Shimamoto, H. Daida, 2007 .

Goals of dyslipidemia management.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

Committee Report 16 Women

S. Kihara, S. Yamashita, T. Hiro, 2014 .

Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Elderly patients.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

American women ( aged 30 − 55 years at Women

T. Funahashi, K. Shimamoto, H. Daida, 2008 .

Risk Factors of Atherosclerotic Diseases

T. Funahashi, K. Shimamoto, H. Daida, 2007 .

Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

Effect of dietary cholesterol on production of lipoproteins and apolipoproteins by perfused livers from Japanese monkeys (Macaca fuscata)

T. Teramoto, Y. Hashimoto, T. Watanabe, 1987, European journal of clinical investigation.

Treatment--drug therapy.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

Committee Report 14 Cerebrovascular Diseases

S. Kihara, S. Yamashita, T. Hiro, 2014 .

Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA.

Y. Yazaki, H. Shimano, T. Teramoto, 1993, Biochemical and biophysical research communications.

Diagnosis of Atherosclerosis

S. Kihara, S. Yamashita, T. Hiro, 2014 .

Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Enhanced susceptibility of LDL to oxidative modification in a CTX patient:- role of chenodeoxycholic acid in xanthoma formation.

S. Kubota, T. Teramoto, M. Kinoshita, 2004, Journal of atherosclerosis and thrombosis.

Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL.

T. Teramoto, M. Okazaki, M. Kinoshita, 2004, Atherosclerosis.

CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese.

Y. Ozaki, S. Kume, S. Hosogaya, 1996, Atherosclerosis.

Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Doxazosin, an α1-adrenergic antihypertensive agent, decreases serum oxidized LDL

T. Teramoto, K. Kojima, M. Kinoshita, 2001 .

Evaluation of niceritrol and pravastatin combination therapy for hyperlipidemia

T. Teramoto, M. Kinoshita, Hiroaki Suzuki, 1998 .

Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome.

K. Shimamoto, T. Teramoto, H. Ohnishi, 2009, Journal of atherosclerosis and thrombosis.

Skipping of exon 14 and possible instability of both the mRNA and the resultant truncated protein underlie a common cholesteryl ester transfer protein deficiency in Japan.

Y. Yazaki, S. Ishibashi, T. Teramoto, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Metabolic syndrome.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

Determination of apolipoprotein B-48 in serum by a sandwich ELISA.

T. Teramoto, M. Kinoshita, M. Kojima, 2005, Clinica chimica acta; international journal of clinical chemistry.

Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases.

K. Nakajima, T. Teramoto, T. Nakano, 2008, Clinica chimica acta; international journal of clinical chemistry.

Serum from methimazole-treated patients induces activation of aryl hydrocarbon receptor, a transcription factor that binds to dioxin-response elements.

J. Jameson, H. Okinaga, T. Teramoto, 2012, Thyroid : official journal of the American Thyroid Association.

Effect of chylomicron remnants on apolipoprotein E synthesis in HepG2 cells.

T. Teramoto, Y. Hashimoto, T. Watanabe, 1994, Metabolism: clinical and experimental.

Familial hypercholesterolemia.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Apolipoprotein E accelerates the efflux of cholesterol from macrophages: mechanism of xanthoma formation in apolipoprotein E deficiency.

T. Teramoto, M. Kawamura, T. Maeda, 2000, Journal of atherosclerosis and thrombosis.

Critical promoter region for statin-induced human endothelial nitric oxide synthase (eNOS) transcription in EA.hy926 cells.

T. Teramoto, M. Kinoshita, Toshio Ishikawa, 2013, Journal of atherosclerosis and thrombosis.

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia

S. Yamashita, T. Okamura, H. Arai, 2020, Journal of atherosclerosis and thrombosis.

Characterization of low-density-lipoprotein in apolipoprotein E deficiency in a patient without coronary atherosclerosis.

S. Suga, T. Teramoto, M. Kawamura, 1996, Clinica chimica acta; international journal of clinical chemistry.

Serum platelet-activating factor acetylhydrolase activity in patients with atopic dermatitis.

Shinichi Watanabe, K. Yamaoka, T. Ohnishi, 2003, Journal of dermatological science.

Role of microsomal triglyceride transfer protein in induction of fatty liver in suncus

N. Matsuki, T. Teramoto, T. Maeda, 1999 .

Primary hyperlipidemia.

T. Funahashi, K. Shimamoto, H. Daida, 2008, Journal of atherosclerosis and thrombosis.

[Fibric acid derivatives].

M. Kinoshita, 1999, Nihon rinsho. Japanese journal of clinical medicine.

Potent and preferential inhibition of Ca2+/calmodulin-dependent protein kinase II by K252a and its derivative, KT5926.

S. Nakanishi, T. Teramoto, K. Kurokawa, 1991, Biochemical and biophysical research communications.

Prostaglandin F2 alpha enhances tyrosine phosphorylation and DNA synthesis through phospholipase C-coupled receptor via Ca(2+)-dependent intracellular pathway in NIH-3T3 cells.

K. Kurokawa, A. Nakao, Y. Hashimoto, 1994, The Journal of biological chemistry.

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

S. Kihara, S. Yamashita, T. Hiro, 2018, Journal of atherosclerosis and thrombosis.

Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.

H. Hara, H. Ishikawa, T. Teramoto, 2008, Journal of nutritional science and vitaminology.

Abnormal high density lipoprotein of primary biliary cirrhosis analyzed by high performance liquid chromatography.

T. Teramoto, Y. Hashimoto, H. Oka, 1985, Clinica chimica acta; international journal of clinical chemistry.

Ca2+ entry pathways activated by the tumor promoter thapsigargin in human platelets.

T. Watanabe, M. Togo, Y. Matsuda, 1993, Biochimica et biophysica acta.

Diagnostic criteria for dyslipidemia.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

The Effects of Combination Therapy with Niceritrol and Pravastatin on Hyperlipidaemia

T. Teramoto, M. Kinoshita, T. Matsushima, 2002, The Journal of international medical research.

Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese.

T. Funahashi, K. Shimamoto, H. Daida, 2007, Journal of atherosclerosis and thrombosis.

The elderly.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Inhibition of platelet function by high-density lipoprotein from a patient with apolipoprotein E deficiency.

S. Kume, T. Teramoto, K. Kurokawa, 1991, Biochemical and biophysical research communications.

Patient health literacy and patient-physician information exchange during a visit.

Y. Yamazaki, H. Ishikawa, E. Yano, 2009, Family practice.

Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein.

H. Arai, T. Teramoto, K. Kurokawa, 1993, Journal of lipid research.

Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

2 Diagnostic Criteria for Dyslipidemia

T. Funahashi, K. Shimamoto, H. Daida, 2007 .

Determination by PCR-RFLP of apo E genotype in a Japanese population.

T. Teramoto, K. Kurokawa, Y. Hashimoto, 1993, The Journal of laboratory and clinical medicine.

Treatment B) Drug Therapy

S. Kihara, S. Yamashita, T. Hiro, 2013 .

Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

Enzyme-linked immunosorbent assay for cholesteryl ester transfer protein in human serum.

H. Arai, T. Teramoto, Y. Saito, 1995, Clinica chimica acta; international journal of clinical chemistry.

Defect in assembly process of very-low-density lipoprotein in suncus liver: an animal model of fatty liver.

N. Matsuki, H. Saito, T. Teramoto, 1995, Journal of biochemistry.

Defect in an intrahepatic degradation of apolipoprotein B in suncus: an animal model of hypobetalipoproteinemia.

N. Matsuki, H. Saito, T. Teramoto, 1998, Journal of biochemistry.

Role of acyl coenzyme A cholesterol acyltransferase in intrahepatic processing of apo B-lipoprotein in suncus.

N. Matsuki, H. Saito, S. Suga, 1995, Journal of biochemistry.

The basic apolipoprotein A-I in the patients with familial lecithin:cholesterol acyltransferase deficiency.

T. Teramoto, Y. Hashimoto, H. Oka, 1986, Scandinavian journal of clinical and laboratory investigation.

Effect of starving and refeeding on lipid metabolism in suncus.

N. Matsuki, H. Saito, T. Teramoto, 1994, Journal of biochemistry.

Evaluating medical students' non‐verbal communication during the objective structured clinical examination

H. Hashimoto, H. Ishikawa, E. Yano, 2006, Medical education.

Determination of immuno-reactive rabbit apolipoprotein B-48 in serum by ELISA.

T. Teramoto, M. Kinoshita, Yamato Mashimo, 2010, Experimental animals.

Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages.

T. Teramoto, K. Kojima, M. Kinoshita, 2002, Journal of atherosclerosis and thrombosis.

Partial purification of the apolipoprotein E receptor of rat liver membrane.

T. Teramoto, Y. Hashimoto, H. Oka, 1985, Journal of biochemistry.

Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging.

T. Teramoto, T. Okazaki, R. Maeba, 2007, Journal of atherosclerosis and thrombosis.

Doxazosin, an alpha1-adrenergic antihypertensive agent, decreases serum oxidized LDL.

T. Teramoto, K. Kojima, M. Kinoshita, 2001, American journal of hypertension.

Time-dependent inhibition of the cyclooxygenase pathway by 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid.

T. Teramoto, Y. Hashimoto, H. Oka, 1985, Biochemical and biophysical research communications.

Absolute risk of cardiovascular disease and lipid management targets.

S. Kihara, S. Yamashita, T. Hiro, 2013, Journal of atherosclerosis and thrombosis.

Binding of vitamin D to low-density-lipoprotein (LDL) and LDL receptor-mediated pathway into cells.

E. Ogata, T. Teramoto, N. Kubodera, 1995, Biochemical and biophysical research communications.

Chronic kidney disease.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.

Isolation and characterization of apolipoprotein B48-containing lipoproteins with a monoclonal antibody against apolipoprotein B48.

T. Teramoto, M. Kinoshita, N. Yoshimura, 2009, Journal of atherosclerosis and thrombosis.

Elderly patients.

H. Tamekiyo, M. Otsuka, Y. Hayashi, 2008, Journal of atherosclerosis and thrombosis.

The elderly.

S. Kihara, S. Yamashita, T. Hiro, 2014, Journal of atherosclerosis and thrombosis.